Skip to main content

A disruptive medical device to enable proton therapy as non-invasive and automated treatment of heart arrhythmias

Project description

Non-invasive cardiac arrhythmia ablation with proton therapy

Heart arrhythmia affects millions of people and the numbers are expected to grow due to the aging populations and lifestyle changes. The current standard catheter ablation procedure requires hospitalisation and has a high risk of complications, such as bleeding, infection, and damage to heart valves or blood vessels. Swiss EBAMed developed a non-invasive device, Cardio-kit, for the treatment of heart arrhythmia using proton therapy. It monitors the heart in real-time and automatically adjusts the stop/go signal to the proton therapy machine based on the cardiac cycle, providing accurate, effective and safe treatment of the moving target within the heart. The EU-funded Cardio-kit project will enable optimisation of the Cardio-kit hardware and software and start of clinical validation procedures necessary for commercialisation in Europe.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-EIC-SMEInst-2018-2020-3

Coordinator

EBAMED SA
Net EU contribution
€ 2 405 025,00
Address
Avenue De Secheron 15
1202 Geneve
Switzerland

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 1 627 000,00